PR Newswire Clinical TrialsOriginal article
Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis
Phase 3positiveXIAFLEXPositive
AI Analysis
Summary
Keenova Therapeutics announced positive Phase 3 clinical trial results for XIAFLEX (collagenase clostridium histolyticum) in treating plantar fibromatosis. The positive outcome supports potential advancement toward regulatory submission.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
Positive Phase 3 results announced
Importance:7/10
Sentiment:
0.80
Phase 3positive dataXIAFLEXplantar fibromatosiscollagenase
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 8, 2026 11:00 AM